Quarterly report · Q1
2590.TEDINET S100QVFN
Period2023-01-21 → 2023-04-20
Filed2023-06-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.1bn | 2023-01-21 → 2023-04-20 | Cons. | Net sales |
| Revenue | ¥160.1bn | 2022-01-21 → 2023-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥34.9bn | 2022-01-21 → 2022-04-20 | Cons. | Net sales |
| Operating income | −¥539m | 2023-01-21 → 2023-04-20 | Cons. | Operating income |
| Operating income | −¥986m | 2022-01-21 → 2022-04-20 | Cons. | Operating income |
| Ordinary income | −¥442m | 2023-01-21 → 2023-04-20 | Cons. | Ordinary income |
| Ordinary income | ¥591m | 2022-01-21 → 2023-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2022-01-21 → 2022-04-20 | Cons. | Ordinary income |
| Profit before tax | −¥87m | 2023-01-21 → 2023-04-20 | Cons. | Income before income taxes |
| Profit before tax | −¥1.2bn | 2022-01-21 → 2022-04-20 | Cons. | Income before income taxes |
| Net income (owners) | −¥296m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥507m | 2022-01-21 → 2023-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.6bn | 2022-01-21 → 2022-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥299m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss |
| Net income | −¥1.6bn | 2022-01-21 → 2022-04-20 | Cons. | Profit loss |
| Total assets | ¥179.1bn | at 2023-04-20 | Cons. | Assets |
| Total assets | ¥164.2bn | at 2023-01-20 | Cons. | Assets |
| Total assets | ¥165.3bn | at 2022-04-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥90.6bn | at 2023-04-20 | Cons. | Liabilities |
| Total liabilities | ¥80.1bn | at 2023-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥88.5bn | at 2023-04-20 | Cons. | Net assets |
| Net assets / equity | ¥84.1bn | at 2023-01-20 | Cons. | Net assets |
| Net assets / equity | ¥83.0bn | at 2022-04-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.2bn | at 2023-04-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.2bn | at 2023-01-20 | Cons. | Cash and deposits |
| EPS (basic) | ¥-18.9 | 2023-01-21 → 2023-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.4 | 2022-01-21 → 2023-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-99.09 | 2022-01-21 → 2022-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 48.4% | at 2023-04-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2023-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.9% | at 2022-04-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2023-04-20 | −¥151m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥238m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥133m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥84m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥63m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| —segment total | revenue | 2023-01-21 → 2023-04-20 | ¥47.2bn |
| —segment total | revenue external | 2023-01-21 → 2023-04-20 | ¥47.1bn |
| —segment total | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥77m |
| —segment total | segment profit | 2023-01-21 → 2023-04-20 | −¥387m |
| Reconciling Itemsreconciling | revenue | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | segment profit | 2022-01-21 → 2022-04-20 | −¥270m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥325m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥96m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | ¥234m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥3.1bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥3.1bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥499m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥2.9bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥2.7bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥120m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥28m |
| —segment total | revenue | 2022-01-21 → 2022-04-20 | ¥35.0bn |
| —segment total | revenue external | 2022-01-21 → 2022-04-20 | ¥34.9bn |
| —segment total | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥134m |
| —segment total | segment profit | 2022-01-21 → 2022-04-20 | −¥715m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 393
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)千 田 健 悟 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)松 川 正 希 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 34912000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 47102000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 160130000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -1130000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -442000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 591000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -1551000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -296000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -507000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 2672000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 2139000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 4105000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 83017000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 88498000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 84067000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 165334000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 179107000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 164204000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -99.09 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -18.90 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -32.40 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.499 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.484 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.509 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 16568500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 16568500 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 16568500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 16568500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 675800 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember | 2000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 15876000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 158760 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 14700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 16568500 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 158760 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 675800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 675800 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |